130 related articles for article (PubMed ID: 3047731)
41. [Pharmacology and therapeutics: oral antidiabetic agents - usage and current trends].
Beltrán Lendinez M; Parras Puche M; Liebanas Pegalajar C; García Jiménez JA
Rev Enferm; 1982 Feb; 5(44):13-8. PubMed ID: 7041228
[No Abstract] [Full Text] [Related]
42. Oral hypoglycemic agents: the pharmacological basis of their clinical use.
Davidoff F
R I Med J; 1973 Oct; 56(10):409-14. PubMed ID: 4518221
[No Abstract] [Full Text] [Related]
43. [Use of oral hypoglycemic agents in diabetic children].
Otto-Buczkowska E
Pol Tyg Lek; 1973; 28(24):904-7. PubMed ID: 4724902
[No Abstract] [Full Text] [Related]
44. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
Jaillard J; Warembourg H
Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429
[No Abstract] [Full Text] [Related]
45. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.
Berger W
Horm Metab Res Suppl; 1985; 15():111-5. PubMed ID: 3865878
[TBL] [Abstract][Full Text] [Related]
46. [Combination therapy of oral hypoglycemic agents which enhance the efficacy of insulin therapy].
Hirose T
Nihon Rinsho; 2012 May; 70 Suppl 3():669-77. PubMed ID: 22768596
[No Abstract] [Full Text] [Related]
47. [Oral antidiabetics today].
Aro A
Duodecim; 1981; 97(12):837-47. PubMed ID: 7297451
[No Abstract] [Full Text] [Related]
48. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
Bell DS
Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
[TBL] [Abstract][Full Text] [Related]
49. [On the use of oral antidiabetic drugs].
Aarseth S
Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1595-601. PubMed ID: 4588815
[No Abstract] [Full Text] [Related]
50. [Experimental and clinical pharmacology of oral antidiabetics].
Cuomo V; Marino A
Clin Ter; 1972 Sep; 62(6):505-52. PubMed ID: 4674507
[No Abstract] [Full Text] [Related]
51. [What is achieved by the therapy with oral antidiabetics?].
Sauer H; Schneider B
Internist (Berl); 1976 Dec; 17(12):604-11. PubMed ID: 827503
[No Abstract] [Full Text] [Related]
52. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
[TBL] [Abstract][Full Text] [Related]
53. Oral hypoglycemic drugs and cardiovascular pathology.
Mincu I; Cheţa D
Med Interne; 1979; 17(2):111-23. PubMed ID: 382336
[TBL] [Abstract][Full Text] [Related]
54. [Adverse effects of sulfonylurea drugs].
Kondo T; Yoshioka N; Koike T
Nihon Rinsho; 2007 Oct; 65 Suppl 8():178-81. PubMed ID: 18074535
[No Abstract] [Full Text] [Related]
55. [Treatment of diabetes mellitus with hypoglycemic agents by oral route].
Confalonieri C
Resen Clin Cient; 1970; 39(9):213-20. PubMed ID: 4921155
[No Abstract] [Full Text] [Related]
56. Oral hypoglycemic agents in type II diabetes mellitus.
Lubbos H; Miller JL; Rose LI
Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
[TBL] [Abstract][Full Text] [Related]
57. [Oral antidiabetics].
Bally C; Assal JP
Ther Umsch; 1979 Nov; 36(11):1000-3. PubMed ID: 538739
[No Abstract] [Full Text] [Related]
58. Oral hypoglycaemic agents.
Borthwick LJ; Stowers JM
Practitioner; 1979 Mar; 222(1329):358-66. PubMed ID: 450836
[No Abstract] [Full Text] [Related]
59. [Oral antidiabetic agents: what are the choices?].
Crausaz FM
Rev Med Suisse Romande; 1991 Aug; 111(8):701-5. PubMed ID: 1925244
[No Abstract] [Full Text] [Related]
60. Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.
Holstein A; Hammer C; Hahn M; Kulamadayil NS; Kovacs P
Expert Opin Drug Saf; 2010 Sep; 9(5):675-81. PubMed ID: 20553106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
